RCM
CEROW

Rivernorth Capital Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Rivernorth Capital Management’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-24,998
Closed -$362 – 379
2025
Q1 		$362 Hold
24,998
– – ﹤0.01% 355
2024
Q4 		$207 Hold
24,998
– – ﹤0.01% 407
2024
Q3 		$127 Hold
24,998
– – ﹤0.01% 386
2024
Q2 		$500 Hold
24,998
– – ﹤0.01% 433
2024
Q1 		$1.75K Hold
24,998
– – ﹤0.01% 423
2023
Q4 		$750 Hold
24,998
– – ﹤0.01% 456
2023
Q3 		$1.75K Hold
24,998
– – ﹤0.01% 501
2023
Q2 		$1.5K Hold
24,998
– – ﹤0.01% 538
2023
Q1 		$750 Hold
24,998
– – ﹤0.01% 625
2022
Q4 		$1K Hold
24,998
– – ﹤0.01% 690
2022
Q3 		$4K Hold
24,998
– – ﹤0.01% 760
2022
Q2 		$3K Hold
24,998
– – ﹤0.01% 759
2022
Q1 		$5K Hold
24,998
– – ﹤0.01% 795
2021
Q4 		$10K Buy
+24,998
New +$11.5K ﹤0.01% 694

Other funds holding CEROW

CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Rivernorth Capital Management's CEROW Position: Q2 2025 in Review

Rivernorth Capital Management sold out of CERo Therapeutics Warrants (CEROW) in Q2 2025, closing a stake of 24,998 shares — an estimated $362 sold.

Rivernorth Capital Management first reported a position in CEROW in Q4 2021 and held it in 14 quarters. The position peaked at $10K in Q4 2021. 23 funds tracked by Wall St. Rank hold CEROW as of Q2 2025.

  • Rivernorth Capital Management reported no remaining CERo Therapeutics Warrants position as of Q2 2025 after selling out during the quarter.
  • Rivernorth Capital Management sold 24,998 CERo Therapeutics Warrants shares in Q2 2025, an estimated $362.
  • Rivernorth Capital Management first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 14 quarters.
  • Rivernorth Capital Management's CERo Therapeutics Warrants position peaked at $10K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q2 2025.

Based on Rivernorth Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.